Modern Chinese Medicine Group Co (HKSE:01643) Long-Term Debt: HK$0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01643 Modern Chinese Medicine Group Co Ltd HKSE:01643
58 GF Score
Price HK$0.79
GF Value HK$0.15
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Modern Chinese Medicine Group Co Long-Term Debt?

Modern Chinese Medicine Group Co HKSE:01643 -7.06% 58 Long-Term Debt is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:01643 with a GF Score™ of 58/100 and a GF Value™ of HK$0.15 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Modern Chinese Medicine Group Co's Long-Term Debt for the quarter that ended in Dec. 2025 was HK$0.0 Mil.

Modern Chinese Medicine Group Co  (HKSE:01643) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Modern Chinese Medicine Group Co Long-Term Debt Related Terms

Modern Chinese Medicine Group Co Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Modern Chinese Medicine Group Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modern Chinese Medicine Group Co Long-Term Debt Chart

Modern Chinese Medicine Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Modern Chinese Medicine Group Co Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:01643
58GF Score
Modern Chinese Medicine Group Co Ltd HKSE:01643
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of HK$0.0 Mil mean?
Modern Chinese Medicine Group Co (HKSE:01643) has a Long-Term Debt of HK$0.0 Mil as of Dec. 2025.
Is Modern Chinese Medicine Group Co's Long-Term Debt too high?
Modern Chinese Medicine Group Co's current Long-Term Debt is HK$0.0 Mil. Overall, Modern Chinese Medicine Group Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Modern Chinese Medicine Group Co's Long-Term Debt compare to LLY and JNJ?
Modern Chinese Medicine Group Co's Long-Term Debt of HK$0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Modern Chinese Medicine Group Co's current Long-Term Debt is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Chinese Medicine Group Co stock overvalued right now?
Based on GuruFocus' analysis, Modern Chinese Medicine Group Co (HKSE:01643) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.79 — trading 426.7% above its estimated fair value. The current Long-Term Debt is HK$0.0 Mil. Modern Chinese Medicine Group Co's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Modern Chinese Medicine Group Co (HKSE:01643), the current Long-Term Debt is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Modern Chinese Medicine Group Co (HKSE:01643) Overvalued in 2026?

Based on GuruFocus' analysis, Modern Chinese Medicine Group Co stock appears to be overvalued. The current stock price of HK$0.79 is trading 426.7% above its estimated GF Value™ of HK$0.15. GuruFocus considers Modern Chinese Medicine Group Co to be Significantly Overvalued.

Key valuation signals for HKSE:01643:

  • Long-Term Debt: HK$0.0 Mil
  • GF Value™: HK$0.15 vs. price of HK$0.79 (426.7% above fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the HKSE:01643 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Modern Chinese Medicine Group Co Business Description

Address No. 88 Jinwei Road, Hebei Province, Longhua County, Chengde, CHN, 068150
Modern Chinese Medicine Group Co Ltd is engaged in the production of Proprietary Chinese Medicines. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include liver protection tablets, Shanmei capsules, Qi and blood supplement pills, and Xiaohuoluo pills, among others. Geographically, the company derives its key revenue from the People's Republic of China.
58GF Score

Get the complete analysis for HKSE:01643

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.79
Price
HK$0.15
GF Value